Vesugen

Vesugen is a synthetic tripeptide (Lys-Glu-Asp) from the Khavinson bioregulator family — one of Peptigrity's bioregulator peptides, researched for vascular-endothelial-targeted bioregulation and blood vessel function. It is sequence-identical to Testagen — both are Lys-Glu-Asp tripeptides, with the Khavinson framework attributing their different proposed tissue targets to context-dependent effects. Vesugen is not approved by the FDA, EMA, or any major Western regulator and is sold as a research-use-only compound by third-party laboratories.

What is Vesugen and how does the vascular bioregulatory mechanism work?

Vesugen is a synthetic Lys-Glu-Asp tripeptide proposed to enter vascular endothelial cell nuclei and modulate gene expression in pathways related to endothelial function, vascular tone, and blood vessel maintenance. Within the Khavinson framework, Vesugen is the vascular-targeted complement to organ-specific bioregulators like Cardiogen (cardiac muscle) and Pinealon (pineal/brain). The Lys-Glu-Asp sequence is shared with Testagen.

Evidence level: Preclinical; Khavinson-group research; independent replication limited

What does the research show for Vesugen?

The published work on Vesugen comes almost entirely from one group — Vladimir Khavinson's, at the St Petersburg Institute of Bioregulation and Gerontology — and is preclinical (endothelial-cell and rodent aging models, gene-expression endpoints). Human clinical research at FDA-grade Phase 2/3 standards has not been conducted. Any reported human use is single-institution and non-blinded. No Western-standard randomized controlled trial of Vesugen has been published as of August 2026, and independent replication outside this group is limited.

Evidence level: Preclinical; Khavinson-group research; FDA-grade Phase 2/3 not conducted

How does Vesugen compare to other Khavinson bioregulators?

Vesugen is sequence-identical to Testagen at the tripeptide level (Lys-Glu-Asp), with the Khavinson framework attributing the different proposed tissue targets to context-dependent effects. This is the most notable Khavinson-cluster duplication.

What are the documented side effects of Vesugen?

Side effects in available preclinical data and community-reported research use are mild — injection-site reactions are the most common report. Long-term safety in humans at sustained research-use dosing is not characterized at Western clinical standards.

Evidence level: preclinical safety; human long-term unestablished

What is the regulatory status of Vesugen?

Vesugen is not approved by the FDA, EMA, or any major Western regulator as of August 2026. Regulatory context in FDA peptide regulation 2025–2026 timeline.

Why does Vesugen vendor verification matter — and what about the Testagen sequence-identity?

Because Vesugen and Testagen share the identical Lys-Glu-Asp tripeptide sequence, mass spectrometry alone cannot distinguish them — they are the same molecule sold under different names with different proposed targets. Buyers should be aware that purchasing both as if they were distinct compounds is paying twice for one peptide. Independent HPLC purity testing remains the standard quality signal. Guidance in how-to-test-peptides hub.

How does Peptigrity verify Vesugen vendors?

Peptigrity collects independent third-party Certificates of Analysis for Vesugen from shops' official channels and verifies each for authenticity before publishing. Because shops choose which COAs to publish, results reflect the batches shops have made public rather than every production batch — a selection bias we state openly. A community-funded Testing Grant to purchase and test vials anonymously is in development. Tests in the database come from independent labs such as Janoshik Analytical, Freedom Diagnostics, and Chromate. The Vesugen-vs-Testagen distinction (a C-terminal glycine, ~57 Da) is flagged in our verification framework so a mass-spec check confirms the correct peptide. Methodology in how we calculate trust scores.

Frequently asked questions

What does Vesugen do?

Vesugen is proposed to act on vascular endothelial tissue through epigenetic gene-expression modulation, with preclinical research focused on endothelial function and vascular aging markers. Human Phase 2/3 efficacy is not established at Western clinical standards.

Is Vesugen the same compound as Testagen?

No. Vesugen is the tripeptide Lys-Glu-Asp; Testagen is the tetrapeptide Lys-Glu-Asp-Gly — the same three residues plus a C-terminal glycine. They are related but chemically distinct, differ by about 57 Da, and mass spectrometry can distinguish them. The Khavinson framework attributes their different proposed tissue targets (vascular for Vesugen, testicular for Testagen) to context-dependent effects rather than sequence differences. Buyers paying for both as if they were different compounds are paying twice for the same molecule.

Source: Short Peptides Regulate Gene Expression, Khavinson V.Kh., Linkova N.S., Tarnovskaya S.I. (optional, non-blocking follow-up: confirm full author list), Bulletin of Experimental Biology and Medicine, 2016

Is Vesugen legal to purchase?

Vesugen is legal to purchase as a research chemical for laboratory use in most jurisdictions, but it is not approved for human consumption in the US, EU, or most Western markets. Country breakdown in peptide legal status guide.

Will Vesugen be FDA-approved?

No active FDA approval pathway exists for Vesugen as of August 2026.

How can I verify a Vesugen vendor is selling real product?

Independent third-party HPLC certificate of analysis from a lab the vendor does not own or pay, with mass spectrometry identity confirmation. Note that mass spec cannot distinguish Vesugen from Testagen at the peptide level. COA interpretation in red flags in peptide certificates of analysis.

Does Peptigrity recommend a Vesugen dose?

No. Vesugen is not approved for human consumption in Western jurisdictions and Peptigrity is an independent review platform, not a medical authority. Anyone considering use should consult a licensed physician. Compare vendors against the independent Vesugen lab tests on file.

This section is for educational and informational purposes only and does not constitute medical advice. Vesugen is not approved by the FDA or any major Western regulator for human use. Always consult a qualified healthcare provider before using any peptide or research compound. Peptigrity is an independent review platform and does not sell, endorse, or recommend specific products or vendors.